Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Sitagliptin for Benign Thyroid Nodules in T2DM
NCT04298684Phase 4Unknown
- Sponsor
- Pointe-à-Pitre University Hospital
- Start
- Jan 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of metformin in benign thyroid nodule, sponsored by Pointe-à-Pitre University Hospital. Status: unknown.
02
Drugs
metformin
03
Conditions
benign thyroid nodule
Beyond the preview
Go deeper on NCT04298684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04298684.